AirSculpt Technologies, Inc. Common Stock (AIRS) Stock Price

AIRSStock

$1.27−86.56%52W

Market Cap$91.92M

P/E—

PEG Ratio—

Div yield—

Beta2.34

AIRS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-61.24%

Price vs S&P 500 (4W)-46.21%

VGM Score25.59

P/CF (Annual)29.69x

Book Value / Share (Quarterly)$1.47

P/TBV (Annual)2.43x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-3.47%

Cash Flow / Share (Quarterly)$0.01

Price vs S&P 500 (YTD)-47.53%

Gross Margin (TTM)66.23%

Net Profit Margin (TTM)-7.79%

EPS (TTM)$-0.18

10-Day Avg Trading Volume0.84M

EPS Excl Extra (TTM)$-0.18

Revenue Growth (5Y)19.31%

EPS (Annual)$-0.19

Dividend / Share (Annual)$0.00

ROI (Annual)-8.12%

Gross Margin (Annual)65.95%

Net Profit Margin (5Y Avg)-3.01%

Cash / Share (Quarterly)$0.26

Revenue Growth QoQ (YoY)-2.53%

ROA (Last FY)-6.23%

Revenue Growth TTM (YoY)-8.71%

EBITD / Share (TTM)$-0.00

ROE (5Y Avg)-7.33%

Operating Margin (TTM)-8.35%

Cash Flow / Share (Annual)$0.01

P/B Ratio0.88x

P/B Ratio (Quarterly)3.03x

Net Income / Employee (Annual)$-35,400

EV / Revenue (TTM)0.77x

Net Interest Coverage (TTM)-1.90x

ROA (TTM)-6.19%

EV / EBITDA (TTM)141.07x

EPS Incl Extra (Annual)$-0.19

Current Ratio (Annual)0.55x

Quick Ratio (Quarterly)0.61x

3-Month Avg Trading Volume0.77M

52-Week Price Return-86.56%

EV / Free Cash Flow (Annual)168.59x

Revenue / Employee (TTM)$456,700

Tangible BV / Share (Quarterly)$0.98

P/S Ratio (Annual)0.61x

Asset Turnover (Annual)0.81x

52-Week High$12.00

Operating Margin (5Y Avg)1.13%

EPS Excl Extra (Annual)$-0.19

CapEx CAGR (5Y)-8.21%

26-Week Price Return-51.34%

Quick Ratio (Annual)0.36x

13-Week Price Return-71.35%

Total Debt / Equity (Annual)0.64x

Current Ratio (Quarterly)0.79x

Enterprise Value$116.67M

Revenue / Share Growth (5Y)17.33%

Asset Turnover (TTM)0.79x

Revenue / Employee (Annual)$460,100

Pretax Margin (Annual)-11.62%

Cash / Share (Annual)$0.13

3-Month Return Std Dev127.13%

Gross Margin (5Y Avg)65.99%

Net Income / Employee (TTM)$-35,600

EBITDA CAGR (5Y)-39.81%

EBITDA Interim CAGR (5Y)-23.02%

ROE (Last FY)-13.30%

Net Interest Coverage (Annual)-2.45x

EPS Basic Excl Extra (Annual)$-0.19

P/FCF (TTM)9.25x

EV / Free Cash Flow (TTM)153.51x

Total Debt / Equity (Quarterly)0.42x

EPS Incl Extra (TTM)$-0.18

ROI (TTM)-8.15%

P/S Ratio (TTM)0.61x

Pretax Margin (5Y Avg)-2.56%

Revenue / Share (Annual)$2.51

Tangible BV / Share (Annual)$0.79

Free OCF CAGR (5Y)-41.69%

Price vs S&P 500 (52W)-102.10%

Year-to-Date Return-35.61%

5-Day Price Return-21.78%

EPS Normalized (Annual)$-0.19

ROA (5Y Avg)-2.82%

Net Profit Margin (Annual)-7.68%

Month-to-Date Return-27.56%

Cash Flow / Share (TTM)$0.05

EBITD / Share (Annual)$0.02

Operating Margin (Annual)-7.61%

LT Debt / Equity (Annual)0.58x

P/CF (TTM)71.98x

ROI (5Y Avg)-3.85%

LT Debt / Equity (Quarterly)0.32x

EPS Basic Excl Extra (TTM)$-0.18

P/TBV (Quarterly)4.51x

P/B Ratio (Annual)1.41x

Dividend / Share (TTM)$0.00

Pretax Margin (TTM)-11.76%

Book Value / Share (Annual)$1.36

Price vs S&P 500 (13W)-74.03%

Dividend Yield (TTM)0.00%

Beta2.34x

P/FCF (Annual)132.83x

Revenue / Share (TTM)$2.13

ROE (TTM)-12.52%

52-Week Low$1.24

vGradeC

gGradeF

mGradeF

vgmGradeD

AIRS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 10, 2026	$0.02	$0.01	-50.00%(-$0.01)
Q1 2026	May 8, 2026	-$0.02	-$0.01	+50.00%(+$0.01)
Q4 2025	Mar 31, 2026	-$0.02	-$0.02	+0.00%(+$0.00)
Q3 2025	Nov 7, 2025	-$0.01	-$0.04	-166.67%(-$0.03)
Q2 2025	Aug 1, 2025	$0.01	$0.02	+33.33%(+$0.01)

AIRS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

2.29

3.89

Industry Peers — Physicians' Offices(15)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	Revenue Growth TTM (YoY)	Operating Margin (TTM)	ROE (TTM)	Price
AIRSAirSculpt Technologies, Inc. Common Stock	C	F	F	—	-8.7%	-8.3%	-12.5%	$1.27
HIMSHims & Hers Health, Inc.	D	B	D	51.0x	28.0%	-6.0%	-30.0%	$28.07
TDOCTeladoc Health, Inc.	A	C	D	—	-2.1%	-7.5%	-13.1%	$5.67
TOIThe Oncology Institute, Inc. Common Stock	D	A	A	—	35.4%	-6.0%	-482.6%	$7.05
STLNStarling Oncology, Inc. Common Stock	F	A	D	—	38.4%	-4.4%	-482.6%	$6.43
SBCSBC Medical Group Holdings Incorporated Common Stock	B	C	B	10.4x	-6.9%	37.3%	19.3%	$5.16
AUNAAuna S.A.	A	D	C	13.9x	7.8%	13.4%	0.9%	$5.32
LFMDLifeMD, Inc. Common Stock	C	C	F	7.9x	-16.7%	-12.4%	1.7%	$2.34
WSTNWestin Acquisition Corp Class A Ordinary Share	—	—	C	—	—	—	—	$10.21
CCMConcord Medical Services Holding Limited	B	A	D	—	40.1%	-45.0%	-11.6%	$3.63
BMGLBasel Medical Group Ltd Ordinary Shares	C	A	D	—	29.8%	-55.9%	-178.8%	$3.95
SBCWWSBC Medical Group Holdings Incorporated Warrants	—	—	A	—	—	—	—	$0.42
STLNWStarling Oncology, Inc. Warrant	—	—	F	—	—	—	—	$0.02
TOIIWThe Oncology Institute, Inc. Warrant	—	—	F	—	—	—	—	$0.02
WSTNRWestin Acquisition Corp Right	—	—	C	—	—	—	—	$0.16
WSTNUWestin Acquisition Corp Units	—	—	C	—	—	—	—	$10.34

About AirSculpt Technologies, Inc. Common Stock

AirSculpt Technologies Inc operates Elite Body Sculpture, a provider of premium minimally invasive body contouring procedures using its proprietary AirSculpt method. The company derives revenue exclusively from direct medical procedure services, offering custom fat removal to consumers seeking non-surgical body sculpting solutions.